Is oxytocin a promising treatment for schizophrenia?
Abstract
To the extent that chemicals can be fashionable, oxytocin is perhaps the most fashionable chemical in neuroscience today. This nine amino acid peptide is appearing with regular frequency as the sub...
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A number of studies in healthy people and in patients with psychological or psychiatric disorders show that administration of oxytocin leads to negative not positive social effects, suggesting that exogenous oxytocin does not always lead to increased affiliation.
“However, a number of studies in healthy people, as well as in patients with psychological or psychiatric disorders show that administration of oxytocin leads to negative not positive social effects (Epperson et al., 1996; Bartz et al., 2011; Feifel, 2011; Mah et al., 2012), suggesting that exogenous oxytocin does not always lead to increased affiliation.”
From Endogenous peripheral oxytocin measures can give insight into the dynamics of social relationships: a review (2014) · cites this paper as Feifel, 2011
Cites
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690 · see citing works
Theodoridou, A., Rowe, A. C., Penton-Voak, I. S., & Rogers, P. J. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.03.019 · Cited by 318 · see citing works
Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients
Feifel, D., Macdonald, K., Nguyen, A., Cobb, P., Warlan, H., Galangue, B., Minassian, A., Becker, O., Cooper, J., Perry, W., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.039 · Cited by 308 · see citing works
Self-citationPeripheral oxytocin is associated with reduced symptom severity in schizophrenia
Rubin, L. H., Carter, C. S., Drogos, L. L., Pournajafi‐Nazarloo, H., Sweeney, J. A., & Maki, P. M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.09.014 · Cited by 228 · see citing works
Goldman, M. B., Marlow-O’Connor, M., Torres, I. J., & Carter, C. S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.09.019 · Cited by 211 · see citing works
Social Interaction Deficits Caused by Chronic Phencyclidine Administration are Reversed by Oxytocin
Lee, P. R., Brady, D. L., Shapiro, R. A., Dorsa, D. M., & Koenig, J. I. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300722 · Cited by 199 · see citing works
Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls
Beckmann, H., Lang, R. E., & Gattaz, W. F. (1985) · Psychoneuroendocrinology · doi:10.1016/0306-4530(85)90056-3 · Cited by 138 · see citing works
Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating
Feifel, D., & Reza, T. L. (1999) · Psychopharmacology · doi:10.1007/s002130050811 · Cited by 121 · see citing works
Self-citationOxytocin as a natural antipsychotic: a study using oxytocin knockout mice
Caldwell, H. K., Stephens, S. L., & Young, W. S. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002150 · Cited by 108 · see citing works
Cerebrospinal fluid neurophysins in affective illness and in schizophrenia
Linkowski, P., Geenen, V. G., Kerkhofs, M., Mendlewicz, J., & Legros, J. J. (1984) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00461555 · Cited by 89 · see citing works
Bradshaw, C. M. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199234110.003.025 · Cited by 87 · see citing works
Glovinsky, D., Kalogeras, K. T., Kirch, D. G., Suddath, R. L., & Wyatt, R. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90021-3 · Cited by 84 · see citing works
Legros, J. J., GAZZOTTI, C., Carvelli, T., Franchimont, P., Timsit-Berthier, M., von Frenckell, R., & Ansseau, M. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90019-4 · Cited by 69 · see citing works
Jk, M., Berger, K., & Mv, S. (1993) · PubMed · Cited by 64 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Crockford, C., Deschner, T., Ziegler, T. E., & Wittig, R. M. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00068 · Cited by 187 · see citing works
Oxytocin enhances pupil dilation and sensitivity to 'hidden' emotional expressions
Leknes, S., Wessberg, J., Ellingsen, D.-M., Chelnokova, O., Olausson, H., & Laeng, B. (2013) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nss062 · Cited by 151 · see citing works
Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders
Rubin, L. H., Carter, C. S., Bishop, J. R., Pournajafi-Nazarloo, H., Drogos, L. L., Hill, S. K., Ruocco, A. C., Keedy, S. K., Reilly, J. L., Keshavan, M. S., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu027 · Cited by 127 · see citing works
Oxytocin, vasopressin, and the motivational forces that drive social behaviors
Caldwell, H. K., & Albers, H. E. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_390 · Cited by 129 · see citing works
- Authors
- Feifel, D.
- Affiliations
- University of California San Diego Medical Center (US)
- Corresponding author
- Feifel, David
- ORCID
- Feifel, David
- Venue
- Expert Review of Neurotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2011-02
- Volume
- 11
- Issue
- 2
- Pages
- 157-159
- ISSN
- 1473-7175 (ISSN-L)
- 1744-8360
- OpenAlex
- W2148394125
- Cited by
- 29
- References
- 14
- Citations by year
- 2023: 4 · 2021: 1 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 3
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Review of Neurotherapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- oxytocin, schizophrenia, schizophrenia treatment, neuropeptides, social cognition
- MeSH terms
- Humans, Oxytocics, Oxytocin, Schizophrenia, Nootropic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
